-
1
-
-
84893389993
-
Opioids compared to placebo or other treatments for chronic low-back pain
-
Chaparro LE, Smith SA, Moore RA, et al. Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013;8, CD004959.
-
(2013)
Cochrane Database Syst Rev
, vol.8
-
-
Chaparro, L.E.1
Smith, S.A.2
Moore, R.A.3
-
2
-
-
84923158714
-
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop
-
PID: 25581257
-
Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276–286.
-
(2015)
Ann Intern Med
, vol.162
, Issue.4
, pp. 276-286
-
-
Chou, R.1
Turner, J.A.2
Devine, E.B.3
-
3
-
-
84921766370
-
Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology
-
COI: 1:CAS:528:DC%2BC2cXhs12gtb3L, PID: 25267983
-
Franklin GM, American Academy of Neurology. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology. 2014;83(14):1277–1284.
-
(2014)
Neurology
, vol.83
, Issue.14
, pp. 1277-1284
-
-
Franklin, G.M.1
-
4
-
-
84964402250
-
CDC guideline for prescribing opioids for chronic Pain--United States, 2016
-
COI: 1:CAS:528:DC%2BC28Xht1Ojt73L, PID: 26977696
-
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic Pain--United States, 2016. JAMA. 2016;315(15):1624–1645.
-
(2016)
JAMA
, vol.315
, Issue.15
, pp. 1624-1645
-
-
Dowell, D.1
Haegerich, T.M.2
Chou, R.3
-
5
-
-
84943542725
-
Effect of Florida’s prescription drug monitoring program and pill mill laws on opioid prescribing and use
-
PID: 26280092
-
Rutkow L, Chang HY, Daubresse M, et al. Effect of Florida’s prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med. 2015;175(10):1642–1649.
-
(2015)
JAMA Intern Med
, vol.175
, Issue.10
, pp. 1642-1649
-
-
Rutkow, L.1
Chang, H.Y.2
Daubresse, M.3
-
6
-
-
84922337366
-
What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose
-
PID: 25454406
-
Haegerich TM, Paulozzi LJ, Manns BJ, et al. What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug Alcohol Depend. 2014;145:34–47.
-
(2014)
Drug Alcohol Depend
, vol.145
, pp. 34-47
-
-
Haegerich, T.M.1
Paulozzi, L.J.2
Manns, B.J.3
-
7
-
-
85008410274
-
Treating opioid-naïve patients: association of initial opioid prescribing patterns and subsequent long-term use
-
Deyo RA, Hallvik SE, Hildebran C, et al. Treating opioid-naïve patients: association of initial opioid prescribing patterns and subsequent long-term use. J Gen Intern Med. 2016. doi:10.1007/s11606-016-3810-3.
-
(2016)
J Gen Intern Med
-
-
Deyo, R.A.1
Hallvik, S.E.2
Hildebran, C.3
-
8
-
-
84899788047
-
Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008–2011
-
PID: 24589763
-
Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008–2011. JAMA Intern Med. 2014;174(5):802–803.
-
(2014)
JAMA Intern Med
, vol.174
, Issue.5
, pp. 802-803
-
-
Jones, C.M.1
Paulozzi, L.J.2
Mack, K.A.3
-
9
-
-
84964573604
-
Physician continuing education to reduce opioid misuse, abuse, and overdose: many opportunities, few requirements
-
PID: 27137406
-
Davis CS, Carr D. Physician continuing education to reduce opioid misuse, abuse, and overdose: many opportunities, few requirements. Drug Alcohol Depend. 2016;163:100–107.
-
(2016)
Drug Alcohol Depend
, vol.163
, pp. 100-107
-
-
Davis, C.S.1
Carr, D.2
-
10
-
-
85027951554
-
Addressing the overdose epidemic requires timely access to data to guide interventions
-
PID: 26382016
-
Davis CS, Green TC, Zaller ND. Addressing the overdose epidemic requires timely access to data to guide interventions. Drug Alcohol Rev. 2016;35(4):383–386.
-
(2016)
Drug Alcohol Rev
, vol.35
, Issue.4
, pp. 383-386
-
-
Davis, C.S.1
Green, T.C.2
Zaller, N.D.3
|